187 related articles for article (PubMed ID: 31490328)
1. Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents.
Stockstill K; Wahlman C; Braden K; Chen Z; Yosten GL; Tosh DK; Jacobson KA; Doyle TM; Samson WK; Salvemini D
Pain; 2020 Jan; 161(1):177-184. PubMed ID: 31490328
[TBL] [Abstract][Full Text] [Related]
2. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.
Janes K; Little JW; Li C; Bryant L; Chen C; Chen Z; Kamocki K; Doyle T; Snider A; Esposito E; Cuzzocrea S; Bieberich E; Obeid L; Petrache I; Nicol G; Neumann WL; Salvemini D
J Biol Chem; 2014 Jul; 289(30):21082-97. PubMed ID: 24876379
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain.
Stockstill K; Doyle TM; Yan X; Chen Z; Janes K; Little JW; Braden K; Lauro F; Giancotti LA; Harada CM; Yadav R; Xiao WH; Lionberger JM; Neumann WL; Bennett GJ; Weng HR; Spiegel S; Salvemini D
J Exp Med; 2018 May; 215(5):1301-1313. PubMed ID: 29703731
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents.
Doyle TM; Hutchinson MR; Braden K; Janes K; Staikopoulos V; Chen Z; Neumann WL; Spiegel S; Salvemini D
J Neuroinflammation; 2020 Oct; 17(1):314. PubMed ID: 33092620
[TBL] [Abstract][Full Text] [Related]
5. Chronic Morphine-Induced Changes in Signaling at the A
Doyle TM; Largent-Milnes TM; Chen Z; Staikopoulos V; Esposito E; Dalgarno R; Fan C; Tosh DK; Cuzzocrea S; Jacobson KA; Trang T; Hutchinson MR; Bennett GJ; Vanderah TW; Salvemini D
J Pharmacol Exp Ther; 2020 Aug; 374(2):331-341. PubMed ID: 32434943
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain.
Chen Z; Doyle TM; Luongo L; Largent-Milnes TM; Giancotti LA; Kolar G; Squillace S; Boccella S; Walker JK; Pendleton A; Spiegel S; Neumann WL; Vanderah TW; Salvemini D
Proc Natl Acad Sci U S A; 2019 May; 116(21):10557-10562. PubMed ID: 31068460
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
Singh SK; Spiegel S
Adv Biol Regul; 2020 Jan; 75():100670. PubMed ID: 31708456
[TBL] [Abstract][Full Text] [Related]
8. Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents.
Doyle TM; Janes K; Chen Z; Grace PM; Esposito E; Cuzzocrea S; Largent-Milnes TM; Neumann WL; Watkins LR; Spiegel S; Vanderah TW; Salvemini D
Pain; 2020 Sep; 161(9):2107-2118. PubMed ID: 32301840
[TBL] [Abstract][Full Text] [Related]
9. Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.
Janes K; Wahlman C; Little JW; Doyle T; Tosh DK; Jacobson KA; Salvemini D
Brain Behav Immun; 2015 Feb; 44():91-9. PubMed ID: 25220279
[TBL] [Abstract][Full Text] [Related]
10. Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.
Doolen S; Iannitti T; Donahue RR; Shaw BC; Grachen CM; Taylor BK
Pain; 2018 Feb; 159(2):224-238. PubMed ID: 29140922
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels through astrocyte-dependent mechanisms.
Wahlman C; Doyle TM; Little JW; Luongo L; Janes K; Chen Z; Esposito E; Tosh DK; Cuzzocrea S; Jacobson KA; Salvemini D
Pain; 2018 Jun; 159(6):1025-1034. PubMed ID: 29419652
[TBL] [Abstract][Full Text] [Related]
12. Role of Adenosine Kinase in Sphingosine-1-Phosphate Receptor 1-Induced Mechano-Hypersensitivities.
Lauro F; Giancotti LA; Kolar G; Harada CM; Harmon TA; Garrett TJ; Salvemini D
Cell Mol Neurobiol; 2022 Nov; 42(8):2909-2918. PubMed ID: 34773542
[TBL] [Abstract][Full Text] [Related]
13. Establishment of opioid-induced rewarding effects under oxaliplatin- and Paclitaxel-induced neuropathy in rats.
Mori T; Kanbara T; Harumiya M; Iwase Y; Masumoto A; Komiya S; Nakamura A; Shibasaki M; Kanemasa T; Sakaguchi G; Suzuki T
J Pharmacol Sci; 2014; 126(1):47-55. PubMed ID: 25141998
[TBL] [Abstract][Full Text] [Related]
14. Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states.
Little JW; Ford A; Symons-Liguori AM; Chen Z; Janes K; Doyle T; Xie J; Luongo L; Tosh DK; Maione S; Bannister K; Dickenson AH; Vanderah TW; Porreca F; Jacobson KA; Salvemini D
Brain; 2015 Jan; 138(Pt 1):28-35. PubMed ID: 25414036
[TBL] [Abstract][Full Text] [Related]
15. A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.
Janes K; Esposito E; Doyle T; Cuzzocrea S; Tosh DK; Jacobson KA; Salvemini D
Pain; 2014 Dec; 155(12):2560-2567. PubMed ID: 25242567
[TBL] [Abstract][Full Text] [Related]
16. Gaining on Pain.
Emery EC; Wood JN
N Engl J Med; 2018 Aug; 379(5):485-487. PubMed ID: 30067934
[No Abstract] [Full Text] [Related]
17. Participation of transient receptor potential vanilloid 1 in the analgesic effect of duloxetine for paclitaxel induced peripheral neuropathic pain.
Wang J; Zhou F; Zhang S; Mao M; Feng S; Wang X
Neurosci Lett; 2022 Mar; 773():136512. PubMed ID: 35149198
[TBL] [Abstract][Full Text] [Related]
18. Analgesic Effects of Sokeikakketsuto on Chemotherapy-Induced Mechanical Allodynia and Cold Hyperalgesia in Rats.
Nakamura H; Kawashiri T; Kobayashi D; Uchida M; Egashira N; Shimazoe T
Biol Pharm Bull; 2021; 44(2):271-274. PubMed ID: 33518680
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic mGluR5 receptor controls glutamatergic input through protein kinase C-NMDA receptors in paclitaxel-induced neuropathic pain.
Xie JD; Chen SR; Pan HL
J Biol Chem; 2017 Dec; 292(50):20644-20654. PubMed ID: 29074619
[TBL] [Abstract][Full Text] [Related]
20. Targeting the A
Singh AK; Mahalingam R; Squillace S; Jacobson KA; Tosh DK; Dharmaraj S; Farr SA; Kavelaars A; Salvemini D; Heijnen CJ
Acta Neuropathol Commun; 2022 Jan; 10(1):11. PubMed ID: 35093182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]